Screener
CONMED CNMD Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | June 30, 2026 / Weighted Average Amortization Period (Years) | June 30, 2026 / Gross Carrying Amount | June 30, 2026 / Accumulated Amortization | December 31, 2025 / Gross Carrying Amount | December 31, 2025 / Accumulated Amortization |
|---|---|---|---|---|---|
| Intangible assets with definite lives: | 22 | ||||
| Customer and distributor relationships | 24 | $365,103 | $(224,933) | $370,068 | $(221,904) |
| Sales representation, marketing and promotional rights | 25 | 149,376 | (87,000) | 149,376 | (84,000) |
| Developed technology | 18 | 317,904 | (70,781) | 317,904 | (65,281) |
| Patents and other intangible assets | 15 | 85,153 | (56,550) | 87,029 | (57,685) |
| Intangible assets with indefinite lives: | |||||
| Trademarks and tradenames | 86,144 | — | 86,544 | — | |
| $1,003,680 | $(439,264) | $1,010,921 | $(428,870) |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's finite-lived intangible assets, accumulated amortization?
- CONMED (CNMD) reported finite-lived intangible assets, accumulated amortization of $439.26M in Q2 2026.
- How has CONMED's finite-lived intangible assets, accumulated amortization changed year-over-year?
- CONMED's finite-lived intangible assets, accumulated amortization increased by 6.8% year-over-year, from $411.3M to $439.26M.
- What is the long-term trend for CONMED's finite-lived intangible assets, accumulated amortization?
- Over 5 years (2020 to 2025), CONMED's finite-lived intangible assets, accumulated amortization has grown at a 10.8% compound annual growth rate (CAGR), from $257.14M to $428.87M.
Ask your AI about CONMED's finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude